STUDY OBJECTIVES

BCC’s aim in conducting this study is to offer synopsis of the current and future characteristics of the global market for optical coherence tomography (OCT). The key objective is to present a comprehensive analysis and future trend and research of OCT as an important tool for the usage of this technique in imaging.

This report explores present and future different OCT techniques and their usage and developments within the OCT market. This report includes different types of OCT techniques such as time domain and large-field high-speed polarization sensitive system, Fourier domain or spectral domain and time-encoded frequency domain or swept source, full-field optical coherence and optical delay scanning. The improvisation of the market, the setbacks and the needs of the market are discussed in this report. The classification, new developments and usage of these types of techniques are also portrayed in this report.

A detailed analysis of the OCT industry has been conducted. Revenues are broken down by region. Sales figures are estimated for the five-year period from 2012 through 2017.

Applications for OCT are also discussed in this report, with an emphasis of the usage of this technique in different therapeutic categories and various other industries. This report also covers significant patents and their allotments in each category.

Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each type/ technology in light of the new technologies, growing competition and changing customer needs.

REASONS FOR DOING THIS STUDY

Extensive research in the OCT field has revealed its current usage in various applications and its usage in the future. The report also covers current research and developments going on in this field. This report also discusses the usage of OCT techniques over other current imaging techniques such as magnetic resonance imaging and ultrasound imaging. Researchers are exploring the advantages of OCT in newer areas, leading to the increased usage and consumption of these techniques. R&D spending, patents and research in this field are giving a new direction. The advancements, new product launches and the early disease detection awareness influenced the market to grow in the foreseeable future. This study looks at almost all of the systems affected by these factors.

CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE

This study contributes to the areas of market growth in OCT manufacturers and users. Pharmaceutical, biotechnical companies, research institutes and analytical/diagnostic institutes will find this study to be of interest.

SCOPE OF THE STUDY

The scope of this study embraces OCT in medical and other markets. BCC analyzed each market and its applications, regulatory environment, technology, market projections and market shares. Technological issues include the latest trends and developments. The emerging markets for OCT include countries such as India, China, Japan, Korea, Taiwan, Africa, Australia, New Zealand, etc.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this study. BCC conducted a comprehensive literature search, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with manufacturers of OCT technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions and market trends.

INFORMATION SOURCES

Many companies were surveyed to obtain data for this study, including manufacturers and end users of OCT. Data were gathered from various industry sources. BCC spoke with officials within the industry and consulted newsletters, company literature, product literature and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.

ABOUT THE AUTHOR

A team of professionals in the biotechnology industry carried out this study. The project manager was Shalini S. Dewan, who holds a Master’s degree in pharmaceutical chemistry and has over 14 years of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are: Reagents for Chromatography; Spectroscopy: An Enduring Market; Advanced Drug Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging: Global Markets; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market; Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies: Technologies and Global Markets.

REPORT HIGHLIGHTS

This report provides:

• An overview of the global market for optical coherence tomography, including details on system technology segments; this study's focus is on Full Field and Optical Delay OCT
• Analyses of global market trends, with data from 2011 and 2012 and projections of compound annual growth rates (CAGRs) through 2017
• A breakdown of OCT formats, including office/tabletop, catheter-based, and handheld
• Regulatory status of the devices in the U.S., EU, and other regions
• Delineation of the major markets for the technology, including ophthalmology, cardiovascular, oncology, dermatology, and dental applications
• Segmentation of the market by geography, technology, mode of implementation, and type of end user
• Comprehensive company profiles of major players.

Table Of Contents

TABLE OF CONTENTS

CHAPTER 1 INTRODUCTION 2

STUDY OBJECTIVES 2
REASONS FOR DOING THIS STUDY 2
CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE 3
SCOPE OF THE STUDY 3
METHODOLOGY 3
INFORMATION SOURCES 3
ABOUT THE AUTHOR 3
RELATED BCC RESEARCH REPORTS 4
BCC ONLINE SERVICES 4
DISCLAIMER 4

CHAPTER 2 SUMMARY 6

SUMMARY TABLE GLOBAL REVENUE OF OCT MARKET, THROUGH 2017 ($ MILLIONS) 8
SUMMARY FIGURE GLOBAL REVENUE OF OCT MARKET, 2010-2017 ($ MILLIONS) 8

CHAPTER 3 OVERVIEW 10

TABLE 1 MAIN CHARACTERISTICS OF OCT 10
USES OF OPTICAL COHERENCE TOMOGRAPHY 11
TABLE 2 USES OF OPTICAL COHERENCE TOMOGRAPHY 11
ADVANTAGES AND DISADVANTAGES OF OPTICAL COHERENCE TOMOGRAPHY 11
TABLE 3 ADVANTAGES AND DISADVANTAGES OF OPTICAL COHERENCE
TOMOGRAPHY 12
APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY 12
TABLE 4 APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY 13
HISTORY OF OPTICAL COHERENCE TOMOGRAPHY 13
TABLE 5 HISTORICAL DEVELOPMENTS IN OPTICAL COHERENCE TOMOGRAPHY 14
CLASSIFICATION 14
TABLE 6 TYPE OF TECHNOLOGIES USED IN OPTICAL COHERENCE TOMOGRAPHY 15
TABLE 7 MODES OF IMPLEMENTATION IN OPTICAL COHERENCE TOMOGRAPHY 15
TYPES OF TECHNOLOGY 15
TRADITIONAL (TIME DOMAIN) OCT 15
POLARIZATION SENSITIVE (PS)-OCT 16
FREQUENCY DOMAIN OCT 16
Fourier or Spectral Domain OCT 17
Time-Encoded Frequency Domain OCT 17
OTHERS 18
Full-Field Optical Coherence 18
Optical Delay Scanning 18
TABLE 8 COMPARISON OF DIFFERENT OCT TECHNOLOGY 19
MODE OF IMPLEMENTATION 19
OFFICE/TABLETOP OCT 19
CATHETER-BASED OCT 20
HANDHELD OCT DEVICES 20
OCT SPECTROMETERS 21
DOPPLER OPTICAL COHERENCE TOMOGRAPHY (OCT) SYSTEM 21

CHAPTER 4 REGULATORY ASPECTS 23

NEW PRODUCTS APPROVED FROM 2008 TO 2012 24
TABLE 9 NEW OCT PRODUCTS APPROVED FROM 2008 TO 2012 24
RECALLS AND SAFETY ALERTS 27
TABLE 10 RECALLS AND SAFETY ALERTS FROM 2008 TO 2012 28

CHAPTER 5 NEW DEVELOPMENTS 30

NEW PARTNERSHIPS, MERGERS AND ACQUISITION 31
NEW PRODUCTS 32
TABLE 11 NEW OCT INNOVATIONS FROM 2008 TO 2012 33
PIPELINE PRODUCTS 34
TABLE 12 PIPELINE PRODUCTS FOR THE OCT MARKET 36

CHAPTER 6 GLOBAL MARKETS FOR OPTICAL COHERENCE TOMOGRAPHY 38

MARKET BY TYPE 39
MARKET OVERVIEW 39
MARKET REVENUE 41
TABLE 13 GLOBAL REVENUE OF OCT BY TYPE, THROUGH 2017 ($ MILLIONS) 41
FIGURE 1 GLOBAL REVENUE OF OCT BY TYPE, 2010-2017 ($ MILLIONS) 41
MARKET SHARE 42
TABLE 14 MARKET SHARES OF OCT BY TYPE, 2011 (%) 42
FIGURE 2 MARKET SHARES OF OCT BY TYPE, 2011 (%) 42
MARKET BY REGION 42
MARKET OVERVIEW 43
MARKET REVENUE 45
TABLE 15 GLOBAL REVENUE OF OCT BY REGION, THROUGH 2017 ($ MILLIONS) 45
FIGURE 3 GLOBAL REVENUE OF OCT BY REGION, 2010-2017 ($ MILLIONS) 45
MARKET SHARE 46
TABLE 16 GLOBAL MARKET SHARE OF OCT BY REGION, 2011 (%) 46
FIGURE 4 GLOBAL MARKET SHARE OF OCT BY REGION, 2011 (%) 46
MARKET FOR TIME DOMAIN OCT AND POLARIZATION SENSITIVE OCT 47
TABLE 17 GLOBAL REVENUE OF TD-OCT AND PS-OCT BY REGION, THROUGH 2017
($ MILLIONS) 47
FIGURE 5 GLOBAL REVENUE OF TD-OCT AND PS-OCT BY REGION, 2010-2017 ($
MILLIONS) 47
MARKET SHARE 48
TABLE 18 MARKET SHARE OF GLOBAL REVENUE OF TD-OCT AND PS-OCT BY
REGION, 2011 (%) 48
FIGURE 6 MARKET SHARE OF GLOBAL REVENUE OF TD-OCT AND PS-OCT BY
REGION, 2011 (%) 48
MARKET FOR FOURIER DOMAIN AND TIME-ENCODED OCT 49
TABLE 19 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY REGION,
THROUGH 2017 ($ MILLIONS) 49
FIGURE 7 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY REGION,
2010-2017 ($ MILLIONS) 49
MARKET SHARE 50
TABLE 20 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT BY REGION, 2011
(%) 50
FIGURE 8 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT BY REGION, 2011
(%) 50
MARKET FOR FULL-FIELD AND OPTICAL DELAY OPTICAL COHERENCE OCT 51
TABLE 21 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, THROUGH 2017
($ MILLIONS) 51
FIGURE 9 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, 2010-2017 ($
MILLIONS) 51
MARKET SHARE 52
TABLE 22 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 52
FIGURE 10 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 52
MARKET BY END USERS 53
MARKET OVERVIEW 54
MARKET REVENUE 59
TABLE 23 GLOBAL MARKET OF OCT BY END USERS, THROUGH 2017 ($ MILLIONS) 60
FIGURE 11 GLOBAL MARKET OF OCT BY END USERS, 2010-2017 ($ MILLIONS) 60
MARKET SHARE 61
TABLE 24 GLOBAL MARKET SHARE OF OCT BY END USERS, 2011 (%) 61
FIGURE 12 GLOBAL MARKET SHARE OF OCT BY END USERS, 2011 (%) 61

CHAPTER 7 MARKETS ANALYSIS FOR FULL-FIELD AND OPTICAL DELAY OPTICAL
COHERENCE TOMOGRAPHY 63

MARKET BY TYPE 64
MARKET OVERVIEW 64
MARKET REVENUE 65
TABLE 25 GLOBAL REVENUE OF FF-OCT AND OD-OCT, THROUGH 2017 ($ MILLIONS) 65
FIGURE 13 GLOBAL REVENUE OF FF-OCT AND OD-OCT, 2010-2017 ($ MILLIONS) 65
MARKET SHARE 66
TABLE 26 MARKET SHARE OF FF-OCT AND OD-OCT BY TYPE, 2011 (%) 66
FIGURE 14 MARKET SHARE OF FF-OCT AND OD-OCT BY TYPE, 2011 (%) 66
MARKETS BY REGIONS 67
MARKET OVERVIEW 67
MARKET REVENUE 68
TABLE 27 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, THROUGH 2017
($ MILLIONS) 68
FIGURE 15 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, 2010-2017 ($
MILLIONS) 69
FULL-FIELD OPTICAL COHERENCE OCT 69
TABLE 28 GLOBAL REVENUE OF FF-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 69
FIGURE 16 GLOBAL REVENUE OF FF-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 70
OPTICAL DELAY OCT 70
TABLE 29 GLOBAL REVENUE OF OD-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 70
FIGURE 17 GLOBAL REVENUE OF OD-OCT BY REGION, 2010-2017 ($ MILLIONS) 70
MARKET SHARE 71
TABLE 30 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 71
FIGURE 18 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 71
MARKETS BY END USERS 72
TABLE 31 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY END USERS, THROUGH
2017 ($ MILLIONS) 73
FIGURE 19 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY END USERS, 2010-2017
($ MILLIONS) 73
ENDOSCOPY 74
Market Revenue 74
TABLE 32 GLOBAL REVENUE OF FF-OCT AND OD-OCT IN ENDOSCOPY, THROUGH
2017 ($ MILLIONS) 75
FIGURE 20 GLOBAL REVENUE OF FF-OCT AND OD-OCT IN ENDOSCOPY, 2010-2017
($ MILLIONS) 75
ONCOLOGY 75
Market Revenue 76
TABLE 33 GLOBAL REVENUE OF FF-OCT AND OD-OCT IN ONCOLOGY, THROUGH
2017 ($ MILLIONS) 76
FIGURE 21 GLOBAL REVIEW OF FF-OCT AND OD-OCT IN ONCOLOGY, 2010-2017 ($
MILLIONS) 77
INTERSTITIAL CELL STUDIES 77
Market Revenue 78
TABLE 34 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN INTERSTITIAL CELL
STUDIES, THROUGH 2017 ($ MILLIONS) 78
FIGURE 22 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN INTERSTITIAL CELL
STUDIES, 2010-2017 ($ MILLIONS) 79
OTHERS 79
Market Revenue 80
TABLE 35 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN OTHER CATEGORIES,
THROUGH 2017 ($ MILLIONS) 80
FIGURE 23 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN OTHER CATEGORIES,
2010-2017 ($ MILLIONS) 81
MARKET SHARE 81
TABLE 36 MARKET SHARE OF FF-OCT AND OD-OCT BY END USERS, 2011 (%) 81
FIGURE 24 MARKET SHARE OF FF-OCT AND OD-OCT BY END USERS, 2011 (%) 81
INDUSTRY STRUCTURE 82
FULL-FIELD OPTICAL COHERENCE TOMOGRAPHY 82
Market Leaders 82
TABLE 37 MAJOR MANUFACTURERS IN FF-OCT, 2011 82
Market Share 82
TABLE 38 MARKET SHARE FOR MANUFACTURERS IN FF-OCT, 2011 (%) 83
FIGURE 25 MARKET SHARE FOR MANUFACTURERS IN FF-OCT, 2011 (%) 83
OPTICAL DELAY OPTICAL COHERENCE TOMOGRAPHY 83
Market Leaders 83
TABLE 39 MAJOR MANUFACTURERS IN OD-OCT, 2011 84
Market Share 84
TABLE 40 MARKET SHARE FOR MANUFACTURERS IN OD-OCT, 2011 (%) 84
FIGURE 26 MARKET SHARE FOR MANUFACTURERS IN OD-OCT, 2011 (%) 84

CHAPTER 8 PATENT ANALYSIS 86

PATENTS BY YEAR 86
TABLE 41 NUMBER OF U.S. PATENTS BY YEAR, FROM 2008 TO 2012 86
FIGURE 27 NUMBER OF U.S. PATENTS BY YEAR, FROM 2008 TO 2012 87
PATENTS BY TYPE 87
TABLE 42 NUMBER OF U.S. PATENTS BY TYPE, FROM 2008-2012 87
FIGURE 28 NUMBER OF U.S. PATENTS BY TYPE, FROM 2008-2012 87
PATENTS BY COMPANY 88
TABLE 43 NUMBER OF U.S. PATENTS BY COMPANY, FROM 2008-OCTOBER 2012 89
PATENTS BY COUNTRY 90
TABLE 44 NUMBER OF U.S. PATENTS BY COUNTRY, FROM 2008-2012 90
PATENTS BY ASSIGNEE 90
TABLE 45 NUMBER OF U.S. PATENTS BY ASSIGNEE, FROM 2008-2012 91
FIGURE 29 NUMBER OF U.S. PATENTS BY ASSIGNEE, FROM 2008-2012 91

CHAPTER 9 CURRENT SITUATION 93

CHAPTER 10 COMPANY PROFILES 97

AGFA HEALTHCARE 97
AGILTRON INCORPORATED 97
BAYSPEC, INC. 97
BIOPTIGEN 98
CARL ZEISS MEDITEC 98
HEIDELBERG ENGINEERING 99
HELIOTIS AG 100
IMALUX CORPORATION 100
LIGHTLAB IMAGING 101
MICHELSON DIAGNOSTICS 101
NIDEK CO., LTD. 102
NOVACAM TECHNOLOGIES INC. 102
NINE POINT MEDICAL 103
OPTOS 103
OPTOVUE, INC. 104
OPTOPOL TECHNOLOGY S.A. 105
PHOENIX RESEARCH LABORATORIES, INC. 105
PandP OPTICA 105
SANTEC CORPORATION 106
SHENZHEN MOPTIM IMAGING TECHNIQUE CO. 106
TOMEY 107
TOMOPHASE CORPORATION 107
TOPCON MEDICAL SYSTEMS, INC. 108
TORNADO SPECTRAL SYSTEMS 108
THORLABS INC. 109

CHAPTER 11 APPENDIX I-ABBREVIATIONS 111



LIST OF TABLES

SUMMARY TABLE GLOBAL REVENUE OF OCT MARKET, THROUGH 2017 ($ MILLIONS) 8
TABLE 1 MAIN CHARACTERISTICS OF OCT 10
TABLE 2 USES OF OPTICAL COHERENCE TOMOGRAPHY 11
TABLE 3 ADVANTAGES AND DISADVANTAGES OF OPTICAL COHERENCE
TOMOGRAPHY 12
TABLE 4 APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY 13
TABLE 5 HISTORICAL DEVELOPMENTS IN OPTICAL COHERENCE TOMOGRAPHY 14
TABLE 6 TYPE OF TECHNOLOGIES USED IN OPTICAL COHERENCE TOMOGRAPHY 15
TABLE 7 MODES OF IMPLEMENTATION IN OPTICAL COHERENCE TOMOGRAPHY 15
TABLE 8 COMPARISON OF DIFFERENT OCT TECHNOLOGY 19
TABLE 9 NEW OCT PRODUCTS APPROVED FROM 2008 TO 2012 24
TABLE 10 RECALLS AND SAFETY ALERTS FROM 2008 TO 2012 28
TABLE 11 NEW OCT INNOVATIONS FROM 2008 TO 2012 33
TABLE 12 PIPELINE PRODUCTS FOR THE OCT MARKET 36
TABLE 13 GLOBAL REVENUE OF OCT BY TYPE, THROUGH 2017 ($ MILLIONS) 41
TABLE 14 MARKET SHARES OF OCT BY TYPE, 2011 (%) 42
TABLE 15 GLOBAL REVENUE OF OCT BY REGION, THROUGH 2017 ($ MILLIONS) 45
TABLE 16 GLOBAL MARKET SHARE OF OCT BY REGION, 2011 (%) 46
TABLE 17 GLOBAL REVENUE OF TD-OCT AND PS-OCT BY REGION, THROUGH 2017 ($
MILLIONS) 47
TABLE 18 MARKET SHARE OF GLOBAL REVENUE OF TD-OCT AND PS-OCT BY REGION,
2011 (%) 48
TABLE 19 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY REGION,
THROUGH 2017 ($ MILLIONS) 49
TABLE 20 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT BY REGION, 2011
(%) 50
TABLE 21 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, THROUGH 2017 ($
MILLIONS) 51
TABLE 22 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 52
TABLE 23 GLOBAL MARKET OF OCT BY END USERS, THROUGH 2017 ($ MILLIONS) 60
TABLE 24 GLOBAL MARKET SHARE OF OCT BY END USERS, 2011 (%) 61
TABLE 25 GLOBAL REVENUE OF FF-OCT AND OD-OCT, THROUGH 2017 ($ MILLIONS) 65
TABLE 26 MARKET SHARE OF FF-OCT AND OD-OCT BY TYPE, 2011 (%) 66
TABLE 27 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, THROUGH 2017 ($
MILLIONS) 68
TABLE 28 GLOBAL REVENUE OF FF-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 69
TABLE 29 GLOBAL REVENUE OF OD-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 70
TABLE 30 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 71
TABLE 31 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY END USERS, THROUGH
2017 ($ MILLIONS) 73
TABLE 32 GLOBAL REVENUE OF FF-OCT AND OD-OCT IN ENDOSCOPY, THROUGH
2017 ($ MILLIONS) 75
TABLE 33 GLOBAL REVENUE OF FF-OCT AND OD-OCT IN ONCOLOGY, THROUGH
2017 ($ MILLIONS) 76
TABLE 34 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN INTERSTITIAL CELL
STUDIES, THROUGH 2017 ($ MILLIONS) 78
TABLE 35 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN OTHER CATEGORIES,
THROUGH 2017 ($ MILLIONS) 80
TABLE 36 MARKET SHARE OF FF-OCT AND OD-OCT BY END USERS, 2011 (%) 81
TABLE 37 MAJOR MANUFACTURERS IN FF-OCT, 2011 82
TABLE 38 MARKET SHARE FOR MANUFACTURERS IN FF-OCT, 2011 (%) 83
TABLE 39 MAJOR MANUFACTURERS IN OD-OCT, 2011 84
TABLE 40 MARKET SHARE FOR MANUFACTURERS IN OD-OCT, 2011 (%) 84
TABLE 41 NUMBER OF U.S. PATENTS BY YEAR, FROM 2008 TO 2012 86
TABLE 42 NUMBER OF U.S. PATENTS BY TYPE, FROM 2008-2012 87
TABLE 43 NUMBER OF U.S. PATENTS BY COMPANY, FROM 2008-OCTOBER 2012 89
TABLE 44 NUMBER OF U.S. PATENTS BY COUNTRY, FROM 2008-2012 90
TABLE 45 NUMBER OF U.S. PATENTS BY ASSIGNEE, FROM 2008-2012 91



LIST OF FIGURES

SUMMARY FIGURE GLOBAL REVENUE OF OCT MARKET, 2010-2017 ($ MILLIONS) 8
FIGURE 1 GLOBAL REVENUE OF OCT BY TYPE, 2010-2017 ($ MILLIONS) 41
FIGURE 2 MARKET SHARES OF OCT BY TYPE, 2011 (%) 42
FIGURE 3 GLOBAL REVENUE OF OCT BY REGION, 2010-2017 ($ MILLIONS) 45
FIGURE 4 GLOBAL MARKET SHARE OF OCT BY REGION, 2011 (%) 46
FIGURE 5 GLOBAL REVENUE OF TD-OCT AND PS-OCT BY REGION, 2010-2017 ($
MILLIONS) 47
FIGURE 6 MARKET SHARE OF GLOBAL REVENUE OF TD-OCT AND PS-OCT BY REGION,
2011 (%) 48
FIGURE 7 GLOBAL REVENUE OF FD-OCT AND TIME-ENCODED OCT BY REGION,
2010-2017 ($ MILLIONS) 49
FIGURE 8 MARKET SHARE OF FD-OCT AND TIME-ENCODED OCT BY REGION, 2011 (%) 50
FIGURE 9 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, 2010-2017 ($
MILLIONS) 51
FIGURE 10 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 52
FIGURE 11 GLOBAL MARKET OF OCT BY END USERS, 2010-2017 ($ MILLIONS) 60
FIGURE 12 GLOBAL MARKET SHARE OF OCT BY END USERS, 2011 (%) 61
FIGURE 13 GLOBAL REVENUE OF FF-OCT AND OD-OCT, 2010-2017 ($ MILLIONS) 65
FIGURE 14 MARKET SHARE OF FF-OCT AND OD-OCT BY TYPE, 2011 (%) 66
FIGURE 15 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY REGION, 2010-2017 ($
MILLIONS) 69
FIGURE 16 GLOBAL REVENUE OF FF-OCT BY REGION, THROUGH 2017 ($ MILLIONS) 70
FIGURE 17 GLOBAL REVENUE OF OD-OCT BY REGION, 2010-2017 ($ MILLIONS) 70
FIGURE 18 MARKET SHARE OF FF-OCT AND OD-OCT BY REGION, 2011 (%) 71
FIGURE 19 GLOBAL REVENUE OF FF-OCT AND OD-OCT BY END USERS, 2010-2017 ($
MILLIONS) 73
FIGURE 20 GLOBAL REVENUE OF FF-OCT AND OD-OCT IN ENDOSCOPY, 2010-2017
($ MILLIONS) 75
FIGURE 21 GLOBAL REVIEW OF FF-OCT AND OD-OCT IN ONCOLOGY, 2010-2017 ($
MILLIONS) 77
FIGURE 22 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN INTERSTITIAL CELL
STUDIES, 2010-2017 ($ MILLIONS) 79
FIGURE 23 GLOBAL EXPENDITURE OF FF-OCT AND OD-OCT IN OTHER CATEGORIES,
2010-2017 ($ MILLIONS) 81
FIGURE 24 MARKET SHARE OF FF-OCT AND OD-OCT BY END USERS, 2011 (%) 81
FIGURE 25 MARKET SHARE FOR MANUFACTURERS IN FF-OCT, 2011 (%) 83
FIGURE 26 MARKET SHARE FOR MANUFACTURERS IN OD-OCT, 2011 (%) 84
FIGURE 27 NUMBER OF U.S. PATENTS BY YEAR, FROM 2008 TO 2012 87
FIGURE 28 NUMBER OF U.S. PATENTS BY TYPE, FROM 2008-2012 87
FIGURE 29 NUMBER OF U.S. PATENTS BY ASSIGNEE, FROM 2008-2012 91

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

The 2014 World%s Leading Diagnostic Imaging Companies

The 2014 World%s Leading Diagnostic Imaging Companies

  • $ 14 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $14,500.  Individual company assessments $2,450.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

Future Horizons and Growth Strategies in the Global Diagnostic Imaging Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global Diagnostic Imaging Market 2014: Strategic Assessments of Leading Suppliers

  • $ 14 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $14,500.  Individual company assessments $2,450.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

The 2014 Global Ultrasound Market: Strategic Assessments of Leading Suppliers

The 2014 Global Ultrasound Market: Strategic Assessments of Leading Suppliers

  • $ 12 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $12,500.  Individual company assessments $1,850.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...


1 Companies

Company Profiles

Lumedx Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.